Related Experiment Video
Updated: May 20, 2026

05:13
Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
The cessation in pregnancy incentives trial (CPIT): study protocol for a randomized controlled trial
David M Tappin1, Linda Bauld, Carol Tannahill
1Paediatric Epidemiology and Community Health Unit, Section of Child Health, Division of Developmental Medicine, Glasgow University, Yorkhill Campus, Glasgow, Scotland, U.K. david.tappin@glasgow.ac.uk
Trials
|July 24, 2012
Summary
Financial incentives may help pregnant smokers quit, protecting both mother and infant. This study explores their acceptability and effectiveness in a UK context to inform future trials.
Area of Science:
- Public Health
- Maternal and Child Health
- Health Economics
Background:
- Pregnancy cessation interventions are crucial, as 70% of Scottish women have children.
- Quitting smoking during pregnancy protects infants from miscarriage, low birth weight, and developmental issues.
- Limited evidence exists on the efficacy of financial incentives for pregnant smokers in the UK.
Purpose of the Study:
- To determine if financial incentives are acceptable, effective, and cost-effective for pregnant smokers in the UK.
- To assess the therapeutic efficacy of incentives for smoking cessation in pregnancy.
- To evaluate the feasibility and acceptability of implementing incentive programs.
Main Methods:
- A phase II exploratory randomized controlled trial involving 600 pregnant smokers.
- Comparison of standard care versus standard care plus financial voucher incentives.
- Primary outcome: self-reported smoking in late pregnancy verified by cotinine measurement; secondary: economic and qualitative assessments.
Main Results:
- The study will establish a workable design for a future phase III trial.
- It will provide a framework for assessing the costs and benefits of financial incentives.
- Exploratory data on efficacy, cost-effectiveness, and acceptability will be gathered.
Conclusions:
- This phase II trial is designed to inform a definitive phase III study on financial incentives for pregnant smokers.
- It will establish a framework for evaluating the economic and practical aspects of such interventions.
- Findings will guide future strategies to support smoking cessation in pregnancy.
